Quantity size:
0.2ml
Concentration:
1mg/ml 牛磺酸/β-氨基乙磺酸抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Taurine is conjugated via its amino terminal group with the bile acids chenodeoxycholic acid and cholic acid to form the bile salts sodium taurochenodeoxycholate and sodium taurocholate. The low pKa (1.5) of taurine's sulfonic acid group ensures that this moiety is negatively charged in the pH ranges normally found in the intestinal tract and thus improves the surfactant properties of the cholic acid conjugate. 牛磺酸/β-氨基乙磺酸抗体Taurine has also been implicated in a wide array of other physiological phenomena including inhibitory neurotransmission, long-term potentiation in the striatum/hippocampus, membrane stabilization, feedback inhibition of neutrophil/macrophage respiratory bursts, adipose tissue regulation and calcium homeostasis. The evidence for these claims, when compared against that reported for taurine's role in bile acid synthesis and osmoregulation, is relatively poor. Premature born infants who lack the enzymes needed to convert cystathione牛磺酸/β-氨基乙磺酸抗体 to cysteine may become deficient in taurine. Thus, taurine is a dietary essential nutrient in these individuals. Many therapeutic applications of taurine have been investigated. Some conditions that taurine might be useful in treating include: cardiovascular diseases, hypercholesterolemia, epilepsy and other seizure disorders, macular degeneration, Alzheimer's disease, hepatic disorders, alcoholism, and cystic fibrosis. Recent studies show that taurine supplements taken by mice on a high-fat diet reduced their overall weight. Studies have yet to be done on the effect of taurine on obesity in humans.
牛磺酸/β-氨基乙磺酸抗体Also known as:
2 aminoethanesulfonic acid; Taurine.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Taurine.
●
Immunogen: KLH conjugated to Taurine.
牛磺酸/β-氨基乙磺酸抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl024Bo01内分泌腺来源血管内皮生长因子(EG-VEGF)多克隆抗体Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Hu01内分泌腺来源血管内皮生长因子(EG-VEGF)多克隆抗体Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Mu01内分泌腺来源血管内皮生长因子(EG-VEGF)多克隆抗体Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Ra01内分泌腺来源血管内皮生长因子(EG-VEGF)多克隆抗体Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl025Bo01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Eq01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Gu01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Hu01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Mu01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Ra01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Si01嗜酸粒细胞趋化因子(ECF)多克隆抗体Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl026Hu01趋化因子C-C-基元配体3样蛋白1(CCL3L1)多克隆抗体Polyclonal Antibody to Chemokine C-C-Motif Ligand 3 Like Protein 1 (CCL3L1)
kl026Mu01趋化因子C-C-基元配体3样蛋白1(CCL3L1)多克隆抗体Polyclonal Antibody to Chemokine C-C-Motif Ligand 3 Like Protein 1 (CCL3L1)
kl027Hu01红细胞生成素受体(EPOR)多克隆抗体Polyclonal Antibody to Erythropoietin Receptor (EPOR)
kl027Ra01红细胞生成素受体(EPOR)多克隆抗体Polyclonal Antibody to Erythropoietin Receptor (EPOR)
kl029Bo01E选择素(SELE)多克隆抗体Polyclonal Antibody to Selectin, Endothelium (SELE)
kl029Ca01E选择素(SELE)多克隆抗体Polyclonal Antibody to Selectin, Endothelium (SELE)
kl029Cp01E选择素(SELE)多克隆抗体Polyclonal Antibody to Selectin, Endothelium (SELE)
kl029Eq01E选择素(SELE)多克隆抗体Polyclonal Antibody to Selectin, Endothelium (SELE)
kl029Hu01E选择素(SELE)多克隆抗体Polyclonal Antibody to Selectin, Endothelium (SELE)
kl029Mu01E选择素(SELE)多克隆抗体Polyclonal Antibody to Selectin, Endothelium (SELE)
牛磺酸/β-氨基乙磺酸抗体信息由上海康朗生物科技有限公司为您提供,如您想了解更多关于牛磺酸/β-氨基乙磺酸抗体报价、型号、参数等信息,欢迎来电或留言咨询。除供应牛磺酸/β-氨基乙磺酸抗体外,上海康朗生物科技有限公司还可为您提供氨基乙二酸半醛脱氢酶磷酸泛酰巯基乙胺转移酶抗体、牛磺酸,107-35-7等产品,公司有专业的客户服务团队,是您值得信赖的合作伙伴。